NCT06754631Completed
Efficacy and Safety of Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma in Children Under 12 Years of Age
Source: ClinicalTrials.gov · Last updated 1 Jan 2025
Brief summary (registry, in English)
Asthma affects around 260 million people globally, causing around 0.5 million deaths annually. Pediatric asthma remains a major global public health challenge, significantly affecting the quality of life for many children. Therefore, this study was planned to compare the effects of continuous versus intermittent nebulization of salbutamol in the treatment of acute severe asthma (ASA) in children visiting the emergency department of a tertiary childcare hospital in South Punjab, Pakistan.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 23 Dec 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Muhammad Aamir Latif
- Diseases
- Asthma
- NCT number
- NCT06754631
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 1 Apr 2024 to the primary completion date, 30 Sept 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Children who were prescribed with other first-line therapy, such as adrenaline or 3% NaCl nebulization
Other illness
- Congenital heart disease
- Chronic respiratory disease
- Neurological disorders
Other
- Presented at imminent risk of respiratory arrest
- Children referred from any other hospital with no data available on emergency treatment
Who the study is looking for
- Children of either gender
- Aged 2 to 12 years
- Diagnosed with moderate exacerbation of acute asthma according to British Guidelines on the Management of Asthma, with a clinical asthma score of 8 or more
Age in the registry: 2 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Children's Hospital and The Institute of Child Health Coordinator of this site? Confirm its status | Multan | Pakistan | Unknown status |
| Nishtar Hospital Coordinator of this site? Confirm its status | Multan | Pakistan | Unknown status |
Related publications
- Continuous versus intermittent nebulization of salbutamol in acute Severe asthma in children under 12 years of age.Pak J Med Sci · 2026 · PMID 41737184
This page is information, not medical advice. Discuss any trial with your doctor.